{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreihsrtryzvnjrpqlm6o25z4ldem6qrkvflpwahz2wko2k6wrthp5me",
    "uri": "at://did:plc:5ka4qkui7nvjms7idhte2m4o/app.bsky.feed.post/3mmfvihk4igl2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreiczf5t4t7upzqcvn7mspyrbkvlyzln5xf6obyvkiqimgy2wbb4xki"
    },
    "mimeType": "image/jpeg",
    "size": 131445
  },
  "path": "/2026/05/21/parkinsons-disease-biogen-denali-therapy/?utm_campaign=rss",
  "publishedAt": "2026-05-21T23:39:12.000Z",
  "site": "https://www.statnews.com",
  "tags": [
    "Biotech",
    "biotechnology",
    "chronic diseases",
    "drug development",
    "Pharmaceuticals",
    "STAT+"
  ],
  "textContent": "Biogen and Denali Therapeutics said a closely watched experimental therapy for Parkinson’s disease failed to slow the degenerative brain disorder in a randomized trial.",
  "title": "STAT+: Closely watched experimental Parkinson’s drug fails key clinical trial",
  "updatedAt": "2026-05-22T00:19:02.000Z"
}